IDEXX LABORATORIES INC /DE (IDXX) Share buybacks
- Total buybacks · last 12 months (USD): Value $1.18B; Formula and calculation Trailing-year cash paid for share repurchases. Period ending 2026-06-30..
- Buyback yield · 12 months: Value (m); Formula and calculation Cash paid for share repurchases / current market cap. Period ending 2026-06-30..
Share buybacks
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Total buybacks · last 12 months (USD) | $1.18B | Trailing-year cash paid for share repurchases. Period ending 2026-06-30. |
| Buyback yield · 12 months | (m) | Cash paid for share repurchases / current market cap. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Buybacks · 12 months | 1.18B USD | Payments for Repurchase of Common Stock |
| Market cap | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Total buybacks | Market cap (USD) | Buyback yield |
|---|---|---|---|
| 2026-06-30 | $1.18B | (m) | (m) |
| 2026-03-31 | $1.17B | (m) | (m) |
| 2025-12-31 | $1.22B | (m) | (m) |
| 2025-09-30 | $1.23B | (m) | (m) |
| 2025-06-30 | $1.21B | (m) | (m) |
| 2025-03-31 | $1.08B | (m) | (m) |
| 2024-12-31 | $837.03M | (m) | (m) |
| 2024-09-30 | $627.89M | (m) | (m) |
| 2024-06-30 | $442.20M | (m) | (m) |
| 2024-03-31 | $226.68M | (m) | (m) |
| 2023-12-31 | $71.92M | (m) | (m) |
| 2023-09-30 | $109.09M | (m) | (m) |
| 2023-06-30 | $246.65M | (m) | (m) |
| 2023-03-31 | $553.42M | (m) | (m) |
| 2022-12-31 | $819.71M | (m) | (m) |
| 2022-09-30 | $990.45M | (m) | (m) |
| 2022-06-30 | $999.05M | (m) | (m) |
| 2022-03-31 | $880.81M | (m) | (m) |
| 2021-12-31 | $746.78M | (m) | (m) |
| 2021-09-30 | $502.02M | (m) | (m) |
| 2021-06-30 | $320.79M | (m) | (m) |
| 2021-03-31 | $132.26M | (m) | (m) |
| 2020-12-31 | $182.81M | (m) | (m) |
| 2020-09-30 | $323.50M | (m) | (m) |
| 2020-06-30 | $409.48M | (m) | (m) |
| 2020-03-31 | $430.17M | (m) | (m) |
| 2019-12-31 | $301.66M | (m) | (m) |
| 2019-09-30 | $266.58M | (m) | (m) |
| 2019-06-30 | $254.43M | (m) | (m) |
| 2019-03-31 | $340.13M | (m) | (m) |
| 2018-12-31 | $369.32M | (m) | (m) |
| 2018-09-30 | $317.58M | (m) | (m) |
| 2018-06-30 | $301.65M | (m) | (m) |
| 2018-03-31 | $302.14M | (m) | (m) |
| 2017-12-31 | $282.56M | (m) | (m) |
| 2017-09-30 | $441.22M | (m) | (m) |
| 2017-06-30 | $398.35M | (m) | (m) |
| 2017-03-31 | $314.52M | (m) | (m) |
| 2016-12-31 | $304.09M | (m) | (m) |
| 2016-09-30 | $184.49M | (m) | (m) |
| 2016-06-30 | $258.42M | (m) | (m) |
| 2016-03-31 | $321.81M | (m) | (m) |
| 2015-12-31 | $401.98M | (m) | (m) |
| 2015-09-30 | $458.25M | (m) | (m) |
| 2015-06-30 | $641.63M | (m) | (m) |
| 2015-03-31 | $681.53M | (m) | (m) |
| 2014-12-31 | $618.16M | (m) | (m) |
| 2014-09-30 | $553.82M | (m) | (m) |
| 2014-06-30 | $358.05M | (m) | (m) |
| 2014-03-31 | $374.26M | (m) | (m) |
| 2013-12-31 | $367.76M | (m) | (m) |
| 2013-09-30 | $324.03M | (m) | (m) |
| 2013-06-30 | $283.60M | (m) | (m) |
| 2013-03-31 | $168.42M | (m) | (m) |
| 2012-12-31 | $132.27M | (m) | (m) |
| 2012-09-30 | $180.64M | (m) | (m) |
| 2012-06-30 | $212.09M | (m) | (m) |
| 2012-03-31 | $243.19M | (m) | (m) |
| 2011-12-31 | $255.50M | (m) | (m) |
| 2011-09-30 | $191.95M | (m) | (m) |
| 2011-06-30 | $157.78M | (m) | (m) |
| 2011-03-31 | $125.30M | (m) | (m) |
| 2010-12-31 | $143.09M | (m) | (m) |
| 2010-09-30 | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | (m) |
| 2010-03-31 | (m) | (m) | (m) |
| 2009-12-31 | $83.10M | (m) | (m) |
| 2009-09-30 | (m) | (m) | (m) |
| 2009-06-30 | (m) | (m) | (m) |
| 2008-12-31 | $132.34M | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lantheus Holdings, Inc. (LNTH) | United States | $6.510B | 26.31 |
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |